Area of research
Hepatology · Immunology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Immunotherapy and Immune Responses, Effects and risks of endocrine disrupting chemicals, and Cancer Mechanisms and Therapy.
A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma
Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled Trial
Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions
A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma
Integrated Multi-Omics Landscape of Liver Metastases
Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment
Comparison of clinical outcomes with proximal femoral nail anti-rotation versus bipolar hemiarthroplasty for the treatment of elderly unstable comminuted intertrochanteric fractures
Comprehensive analysis of spatial architecture in primary liver cancer
Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids
Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
The effect of biliary obstruction, biliary drainage and bile reinfusion on bile acid metabolism and gut microbiota in mice
Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression
Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
The miR-561-5p/CX<sub>3</sub>CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX<sub>3</sub>CR1<sup>+</sup> Natural Killer Cells Infiltration
Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis
Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation
Phthalate exposure and childhood overweight and obesity: Urinary metabolomic evidence
Evaluating effects of prenatal exposure to phthalates on neonatal birth weight: Structural equation model approaches
CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis
Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma
Gender-specific relationship between prenatal exposure to phthalates and intrauterine growth restriction